Publications by authors named "Sunil U Nayak"

8Publications

Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism.

Drug Alcohol Depend 2020 04 27;209:107946. Epub 2020 Feb 27.

Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, Philadelphia, PA 19140, USA; Department of Pharmacology, Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, Philadelphia, PA 19140, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2020.107946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127966PMC
April 2020

Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist.

Brain Behav Immun 2020 01 23;83:288-292. Epub 2019 Sep 23.

Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA; Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2019.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906231PMC
January 2020

Predator odor produces anxiety-like behavioral phenotype in planarians that is counteracted by fluoxetine.

Physiol Behav 2019 07 2;206:181-184. Epub 2019 Apr 2.

Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00319384193016
Publisher Site
http://dx.doi.org/10.1016/j.physbeh.2019.04.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520172PMC
July 2019

Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Neuroscience 2018 08 27;386:214-222. Epub 2018 Jun 27.

Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA; Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuroscience.2018.06.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086122PMC
August 2018

Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.

Drug Alcohol Depend 2018 05 10;186:75-79. Epub 2018 Mar 10.

Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University Philadelphia, PA, USA; Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2018.01.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911211PMC
May 2018

Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).

Psychopharmacology (Berl) 2017 Jun 1;234(11):1671-1681. Epub 2017 Mar 1.

Department of Pharmacology, Temple University School of Medicine, 3500 North Broad Street, Philadelphia, PA, 19140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-017-4568-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433920PMC
June 2017

Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.

Neuropharmacology 2016 09 13;108:111-9. Epub 2016 Apr 13.

Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, United States; Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2016.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912874PMC
September 2016